This is the third commercial arrangement for Norwood Immunology group. Abbott, Solvay and now MedImmune. Immunology shares up on AIM last night.
- Forums
- ASX - By Stock
- immunology exclusive agreement with medimmune
This is the third commercial arrangement for Norwood Immunology...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online